Postpartum depression pill zuranolone yields 'significant improvements,' clinical trial data shows

Brasil Notícia Notícia

Postpartum depression pill zuranolone yields 'significant improvements,' clinical trial data shows
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 CBSNews
  • ⏱ Reading Time:
  • 39 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 68%

A pill being developed to treat postpartum depression is showing promise for new parents who suffer from the condition, according to newly released clinical trial data.

, published Wednesday in The American Journal of Psychiatry, found the drug, zuranolone, from makers Sage Therapeutics and partner company Biogen, demonstrated"significant improvements in depressive symptoms and was generally well tolerated."

The late stage, double-blind trial analyzed nearly 200 patients with severe postpartum depression who were given either 50 milligrams per day of zuranolone or a placebo for 14 days. "Treatment with zuranolone compared with placebo resulted in statistically significant improvements in symptoms at day 15," the researchers reported.

The most common adverse effects reported with the drug were somnolence , dizziness and sedation."No loss of consciousness, withdrawal symptoms, or increased suicidal ideation or behavior were observed," the study authors wrote. to be taken as a once-a-day pill for 14 days. It is not yet approved by the Food and Drug Administration, but the agency is expected to make a decision on it in early August.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

CBSNews /  🏆 87. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

New Postpartum Depression Pill Provides 'Significant Improvements' For Struggling Moms In Trial StudyNew Postpartum Depression Pill Provides 'Significant Improvements' For Struggling Moms In Trial StudyZuranolone, a new drug used to treat postpartum depression in new moms, could be approved by the FDA as soon as August.
Consulte Mais informação »

Experts Warn House GOP Bill Would Imperil Food Aid for 5.3 Million Kids and Postpartum Adults'We can't go back in time by letting even more families and babies in need go hungry!' said one mother. 'I implore Congress to act now to ensure WIC receives the full funding it needs.'
Consulte Mais informação »

Postpartum depression pill shows positive effects, new trial data showsPostpartum depression pill shows positive effects, new trial data showsA pill for postpartum depression led to meaningful improvements in depression symptoms, according to a late-stage study published this week.
Consulte Mais informação »

Offering discounts for expiring food could reduce food waste by 21%: UC San Diego reportOffering discounts for expiring food could reduce food waste by 21%: UC San Diego reportDynamic pricing, on the other hand, 'spurs retailers to throw less food out, to begin with by applying an algorithm that determines when grocery stores should reduce the price of perishables depending on their inventory and expiration date.'
Consulte Mais informação »

Postpartum depression pill is safe and effective, new trial data shows | CNNPostpartum depression pill is safe and effective, new trial data shows | CNNThe day after the trial participants completed a 14-day treatment course of zuranolone, the researchers found that 57% reported a 50% or higher improvement in their depressive symptoms, compared with 38% of those on a placebo.
Consulte Mais informação »

A Mom Explains How “People Show Their True Colors” When You Are PostpartumA Mom Explains How “People Show Their True Colors” When You Are PostpartumA TikTok mom is going viral for being honest about how she was treated after she had a baby, and how she's giving that energy right back.
Consulte Mais informação »



Render Time: 2025-03-04 15:18:14